Lai; Gaifa

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lai; Gaifa.The latest application filed is for "heterocyclic aspartyl protease inhibitors".

Company Profile

0.11.13

Lai; Gaifa - Monmouth Junction NJ US
Lai; Gaifa - Edison NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclic aspartyl protease inhibitors Grant 8,829,036 - Zhu , et al. September 9, 2	2014-09-09
Heterocyclic aspartyl protease inhibitors Grant 8,691,831 - Zhu , et al. April 8, 2	2014-04-08
Heterocyclic aspartyl protease inhibitors Grant 8,691,833 - Zhu , et al. April 8, 2	2014-04-08
Heterocyclic Aspartyl Protease Inhibitors App 20120276118 - Zhu; Zhaoning ; et al.	2012-11-01
Heterocyclic Aspartyl Protease Inhibitors App 20120231018 - Zhu; Zhaoning ; et al.	2012-09-13
Heterocyclic Aspartyl Protease Inhibitors App 20120231017 - ZHU; ZHAONING ; et al.	2012-09-13
3,4-Di-Substituted Cyclobutene-1,2-Diones as CXC-Chemokine Receptor Ligands App 20110213029 - Taveras; Arthur G. ; et al.	2011-09-01
3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,964,646 - Taveras , et al. June 21, 2	2011-06-21
Heterocyclic aspartyl protease inhibitors Grant 7,763,609 - Zhu , et al. July 27, 2	2010-07-27
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands Grant 7,691,856 - Taveras , et al. April 6, 2	2010-04-06
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands Grant 7,671,212 - Taveras , et al. March 2, 2	2010-03-02
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands App 20090306079 - Taveras; Arthur G. ; et al.	2009-12-10
Isomeric Purinones And 1h-imidazopyridinones As Pkc-theta Inhibitors App 20090281075 - Roughton; Andrew L. ; et al.	2009-11-12
Heterocyclic aspartyl protease inhibitors App 20080200445 - Zhu; Zhaoning ; et al.	2008-08-21
3,4-di-substituted Cyclobutene-1,2-diones As Cxc-chemokine Receptor Ligands App 20080045489 - Chao; Jianhua ; et al.	2008-02-21
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC-chemokine receptor ligands App 20070264230 - Taveras; Arthur G. ; et al.	2007-11-15
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20070021494 - Taveras; Arthur G. ; et al.	2007-01-25
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands Grant 7,132,445 - Taveras , et al. November 7, 2	2006-11-07
Isothiazole dioxides as CXC- and CC-chemokine receptor ligands App 20060025453 - Taveras; Arthur G. ; et al.	2006-02-02
Thiadiazoledioxides and thiadiazoleoxides as CXC- and CC- chemokine receptor ligands App 20040186142 - Taveras, Arthur G. ; et al.	2004-09-23
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands App 20040147559 - Taveras, Arthur G. ; et al.	2004-07-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.